A break-even analysis of tranexamic acid for prevention of periprosthetic joint infection following total hip and knee arthroplasty
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Journal of Orthopaedics
- Vol. 26, 54-57
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The pre-operative levels of haemoglobin in the blood can be used to predict the risk of allogenic blood transfusion after total knee arthroplastyThe Bone & Joint Journal, 2016
- Cost Analysis of Tranexamic Acid in Anemic Total Joint Arthroplasty PatientsThe Journal of Arthroplasty, 2016
- Quantifying the Burden of Revision Total Joint Arthroplasty for Periprosthetic InfectionThe Journal of Arthroplasty, 2015
- Cost Benefit Analysis of Topical Tranexamic Acid in Primary Total Hip and Knee ArthroplastyThe Journal of Arthroplasty, 2014
- Economic Impact of Tranexamic Acid in Healthy Patients Undergoing Primary Total Hip and Knee ArthroplastyThe Journal of Arthroplasty, 2013
- An Evaluation of the Use of Topical Tranexamic Acid in Total Knee ArthroplastyThe Journal of Arthroplasty, 2013
- Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood lossBritish Journal of Surgery, 2013
- Assessing the Gold Standard: A Review of 253 Two-Stage Revisions for Infected TKAClinical Orthopaedics and Related Research, 2012
- Economic Burden of Periprosthetic Joint Infection in the United StatesThe Journal of Arthroplasty, 2012
- Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?Blood, 2001